Purchase Order 75N95D25P00057

The U.S. Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke awarded a $198,740.56 firm fixed price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for Olink Explore 3072 reagent kits. The contract is for the delivery of these reagents by September 6, 2023. Olink Proteomics has a history of providing various proteomics instruments, reagents, kits, analysis services,...

This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging awarded a firm fixed-price purchase order contract to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, for an EXPLORE 3072 Reagent Kit. The contract has a potential value of $184,037.60 and a completion date of August 31, 2022. Olink Proteomics has been awarded numerous federal contracts from agencies such as NIH, FDA, and Department of Veterans Affairs to...

The Department of Health and Human Services National Institutes of Health National Institute on Aging awarded a $203,298.48 firm fixed-price purchase order to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company, to provide OLINK EXPLORE HT REAGENT KITS. The contract has a completion date of April 24, 2024 and does not have a set-aside designation. The original pre-solicitation notice indicates that the National Institutes of Health National Institute on Drug Abuse is...

This is a firm-fixed-price purchase order awarded by the National Institute on Aging (NIA), a civilian agency within the U.S. Department of Health and Human Services, to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $98,392.48 contract is for the delivery of the Olink Explore 3072 Proteomics Screening Kit, which supports the agency's biomedical research missions in areas such as aging, cancer, and neurodegenerative diseases. Olink Proteomics has a significant...

This is a firm-fixed-price purchase order awarded by the National Institutes of Health (NIH) Clinical Center to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The $14,531.69 contract is for the provision of Olink's proprietary proteomics instruments, reagent kits, integrated fluidic circuits, and analytical services to support biomedical research missions across the NIH, including aging, cancer, neurodegenerative diseases, diabetes, and infectious diseases. Olink...

This is a firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the Department of Health and Human Services (HHS), to Life Technologies Corporation, a subsidiary of Thermo Fisher Scientific. The contract is for a "REAGENT KIT" with a ceiling value of $4,460.00 and a period of performance ending on December 29, 2015. The contract did not utilize any set-aside designations. As a manufacturer of scientific...

This federal contract award to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. Department of Health and Human Services. The $19,785.63 firm-fixed-price purchase order is for Olink assay kits to enable the agency to use their existing Olink equipment and avoid the expense of having samples analyzed by Olink. This award does not have a set-aside designation. Olink Proteomics is...

This is a $18,090.69 firm-fixed-price purchase order awarded by the National Heart Lung and Blood Institute (NHLBI) to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables. The contract is to provide reagents for the KEMPER, LEONARD, ALTAN-BONNET LABS to perform experiments involving immunological and molecular assays of both innate and adaptive immunity. The contract has an ultimate completion date of June 4, 2025 and does not utilize any...

The Food and Drug Administration (FDA) awarded a $94,500 firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned manufacturer of protein biomarker analysis technologies and services. The contract is for quantitative proteomics measurement of cardiotoxicity biomarkers in 150 human plasma samples using Olink's proprietary Explore 1536 multiplex analysis platform. This purchase order was awarded without a set-aside and is not associated with a larger contract vehicle. Olink...